Better outcomes in severe COVID-19 patients administered interleukin-6 inhibitors early
New research from Boston Medical Center found that patients experiencing severe COVID-19 symptoms had improved outcomes when administered an Interleukin-6 (IL6ri) inhibitor, sarilumab or tocilizumab, given to mediate severe ...
Aug 5, 2020
0
4